BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 591411)

  • 21. A 2-Year History of Diplopia, Optic Disc Edema, and Amaurosis.
    Cohen DA; Chen JJ; Leavitt JA
    JAMA Ophthalmol; 2019 Jan; 137(1):103-104. PubMed ID: 30383168
    [No Abstract]   [Full Text] [Related]  

  • 22. Integrative assessment of brain and bone invasion in meningioma patients.
    Zwirner K; Paulsen F; Schittenhelm J; Gepfner-Tuma I; Tabatabai G; Behling F; Skardelly M; Bender B; Zips D; Eckert F
    Radiat Oncol; 2019 Jul; 14(1):132. PubMed ID: 31358024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brachytherapy: a viable alternative in the management of basal meningiomas.
    Kumar PP; Patil AA; Leibrock LG; Chu WK; Syh J; McCaul GF; Reeves MA
    Neurosurgery; 1991 Nov; 29(5):676-80. PubMed ID: 1961396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience.
    Pirzkall A; Debus J; Haering P; Rhein B; Grosser KH; Höss A; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):362-72. PubMed ID: 12527049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient radiographic early enhancement after radiotherapy for meningioma.
    Hallock A; Bauman G
    Can J Neurol Sci; 2012 Jan; 39(1):99-101. PubMed ID: 22384507
    [No Abstract]   [Full Text] [Related]  

  • 26. Postoperative irradiation.
    Lee AG
    Ophthalmology; 1997 Jun; 104(6):898. PubMed ID: 9186422
    [No Abstract]   [Full Text] [Related]  

  • 27. [Recurrent meningioma].
    Philippon J; Bataini JP; Cornu P; Grob R; Kujas M; Poisson M; Rivierez M
    Neurochirurgie; 1986; 32 Suppl 1():1-84. PubMed ID: 3724947
    [No Abstract]   [Full Text] [Related]  

  • 28. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
    Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
    Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New indications of protontherapy for adults intracranial tumours].
    Lesueur P; Doyen J; Lecornu M; Calugaru V; Florescu C; Missohou F; Geffrelot J; Mammar H; Stefan D; Feuvret L; Balosso J
    Cancer Radiother; 2021 Oct; 25(6-7):545-549. PubMed ID: 34175224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brachytherapy as Salvage Treatment for Meningioma With Malignant Progression After Exhausting Other Treatment Options: 2-Dimensional Operative Video.
    Mooney MA; Essayed W; Patel V; Devlin PM; Al-Mefty O
    Oper Neurosurg (Hagerstown); 2022 May; 22(5):e215. PubMed ID: 35426879
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of
    Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
    Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there effective systemic therapy for recurrent surgery- and radiation-refractory meningioma?
    Chamberlain MC
    CNS Oncol; 2013 Jan; 2(1):1-5. PubMed ID: 25054350
    [No Abstract]   [Full Text] [Related]  

  • 35. Adaptive fractionated stereotactic Gamma Knife radiotherapy of meningioma using integrated stereotactic cone-beam-CT and adaptive re-planning (a-gkFSRT).
    Stieler F; Wenz F; Abo-Madyan Y; Schweizer B; Polednik M; Herskind C; Giordano FA; Mai S
    Strahlenther Onkol; 2016 Nov; 192(11):815-819. PubMed ID: 27380001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity-modulated stereotactic radiotherapy vs. stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base.
    Baumert BG; Norton IA; Davis JB
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):580-92. PubMed ID: 12957272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
    Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recurrence and intracranial metastasis of a meningioma].
    del Pozo García JM; Sanjuanbenito Aguirre L; Martínez-Cubells J; Hernando Arribas C; Rodríguez del Barrio E
    Rev Clin Esp; 1981 Dec; 163(5):355-8. PubMed ID: 7342195
    [No Abstract]   [Full Text] [Related]  

  • 39. Managing menacing meningioma.
    Smith JL; McCrary JA; Ray BS; Vuksanovic MM
    J Clin Neuroophthalmol; 1983 Sep; 3(3):169-79. PubMed ID: 6226715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meningioma: a case of transcranial recurrence managed by base-of-skull technique and a review of the tumor.
    Humphreys DH; Schwartz MR; Jenkins HA
    Otolaryngol Head Neck Surg; 1985 Aug; 93(4):563-70. PubMed ID: 3931034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.